QuidelOrtho Corp
QDEL · In Vitro and in Vivo Diagnostic Substances
Latest available SEC filing: 10-Q ·
Latest disclosures
-
Latest financial period: Q3 2026
Financial facts · Filed
-
Form 10-Q
SEC filing · Filed
-
Siegrist Jonathan Philip: Form 4
Insider disclosure · Filed · Report period 15 Oct 2026
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form SCHEDULE 13G
SEC filing · Filed
-
Form 10-Q
SEC filing · Filed
Institutional holders by security
Choose a share class to see reported 13F positions and quarterly changes. Different securities have separate holder histories.
Company details and SEC sources
CIK 0001906324 · SEC filing index. Filing dates describe disclosures, not live market data.
- Listed symbols
- QDEL on Nasdaq
- SEC industry group
- In Vitro and in Vivo Diagnostic Substances (Office of Life Sciences)
- Business address
- 9975 Summers Ridge Road, San Diego, CA, 92121
- Fiscal year end
- 01 January
- Former names on EDGAR
- Coronado Topco, Inc. (to 11 Apr 2022)
At a glance
Names, identifiers, and filing context for this profile.
2 identity fields